Clinical Trials Logo
  1. Home
  2. Multiple Sclerosis
  3. NCT06102148
  4. Details
NCT06102148 Clinical Trial

The Effect Of Proprioceptive Neuromuscular Facilitation Techniqueson in Patients With Multiple Sclerosis

Multiple Sclerosis Clinical Trial

Official title:
The Effect Of Proprioceptive Neuromuscular Facilitation Techniqueson Pain, Motor Functions, Fatique and Health Related Quality of Life in Patients With Multiple Sclerosis: A Randomized, Single-blind Study.

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT06102148
Other study ID # 2021/413
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2021
Est. completion date November 1, 2022

Study information
Verified date October 2023
Source Ondokuz Mayis University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to examine the effects of PNF techniques on pain, motor function, fatigue and quality of life.

Recruitment information / eligibility
Status Completed
Enrollment 44
Est. completion date November 1, 2022
Est. primary completion date November 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - a clinical diagnosis of Relapsing-Remitting MS (RRMS) as defined by McDonald criteria - 18-65 years of age - an Expanded Disability Status Scale (EDSS) score < 4 - relapse-free for the last 3 months - cognitive impairment that was defined with mini mental test. Exclusion Criteria: - a history of different neurological diseases - having any contraindication for exercise - having orthopedic, vision, hearing, or perception problems.

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• PNF Group
Exercise training and PNF training
• Control Group
Exercise training

Locations
Country Name City State
Turkey Ondokuz Mayis University Samsun

Sponsors (1)
Lead Sponsor Collaborator
Nilay Comuk Balci

Country where clinical trial is conducted

Turkey, 

Outcome
Type Measure Description Time frame Safety issue
Primary Visual Analogue Scale (VAS) Pain through study completion, an average of 1 year
Primary Multiple Sclerosis Quality of Life-54 (MSQoL-54) Quality of Life through study completion, an average of 1 year
Primary Fatigue Severity Scale and Fatigue Impact Scale (FIS) Fatigue through study completion, an average of 1 year
Primary Timed Up and Go (TUG) Mobility and Balance through study completion, an average of 1 year
Primary The Six-Minute Walk Test (6-MWT) Functionality through study completion, an average of 1 year
Primary Hand Dexterity Hand Dexterity through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03269175 - BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies Phase 4